Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
61,020,215
-
Share change
-
+3,420,602
-
Total reported value
-
$1,450,530,086
-
Put/Call ratio
-
611%
-
Price per share
-
$23.77
-
Number of holders
-
180
-
Value change
-
+$92,541,482
-
Number of buys
-
88
-
Number of sells
-
78
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2014
As of 31 Dec 2014,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
180 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,020,215 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, OAK RIDGE INVESTMENTS LLC, Bank of New York Mellon Corp, Champlain Investment Partners, LLC, KALMAR INVESTMENTS INC /DE/, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., Invesco Ltd., and GANNETT WELSH & KOTLER.
This page lists
179
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.